VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q2 2023. The put-call ratio across all filers is 4.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $2,179,567 | -69.7% | 31,907 | -72.2% | 0.00% | -73.3% |
Q4 2023 | $7,204,479 | +132.2% | 114,721 | +84.6% | 0.02% | +36.4% |
Q2 2023 | $3,103,322 | -7.2% | 62,141 | -30.3% | 0.01% | -78.0% |
Q1 2023 | $3,342,579 | -53.5% | 89,183 | -40.6% | 0.05% | -61.8% |
Q4 2022 | $7,193,267 | +405.9% | 150,016 | +153.1% | 0.13% | +385.2% |
Q3 2022 | $1,422,000 | -59.9% | 59,260 | -63.7% | 0.03% | -72.4% |
Q2 2022 | $3,550,000 | +111.7% | 163,125 | +134.9% | 0.10% | +117.8% |
Q1 2022 | $1,677,000 | – | 69,452 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,049,893 | $53,523,545 | 17.09% |
Pivotal bioVenture Partners Investment Advisor LLC | 793,036 | $40,429,128 | 16.12% |
Kynam Capital Management, LP | 1,302,407 | $66,396,709 | 10.86% |
RA Capital Management | 7,891,254 | $402,296,129 | 7.92% |
COMMODORE CAPITAL LP | 1,100,000 | $56,078,000 | 6.56% |
GREAT POINT PARTNERS LLC | 531,211 | $27,081,137 | 4.93% |
ACUTA CAPITAL PARTNERS, LLC | 121,022 | $6,169,702 | 4.14% |
Frazier Life Sciences Management, L.P. | 1,164,405 | $59,361,367 | 3.94% |
Novo Holdings A/S | 845,000 | $43,078,100 | 3.18% |
BRAIDWELL LP | 1,619,553 | $82,564,812 | 2.61% |